Spectacular #RAKNYE 2022 Fireworks Show Sets Two GUINNESS WORLD RECORDS™ Titles, Mesmerising Thousands of Visitors
1.1.2022 14:06:00 EET | Business Wire | Press release
Welcoming hundreds of thousands of spectators from around the world, the Ras Al Khaimah New Year’s Eve Celebrations (#RAKNYE 2022) dazzled all with a never-before-seen fireworks display that smashed two GUINNESS WORLD RECORDS™ titles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211231005082/en/
#RAKNYE 2022 Two GUINNESS WORLD RECORDS™ titles (Photo: AETOSWire)
Rising majestically from the Arabian Gulf, the fireworks display featured innovative pyrotechnic performances spanning an area of over 4.7 kilometres. The 12-minute spectacle was specially choreographed to reflect the joy of reunion with six themes set to epic orchestral music.
A spokesperson of the organising committee said: “#RAKNYE2022 is our tribute to the leadership and people of Ras Al Khaimah and the UAE not only as we celebrate the 50th Anniversary of our nation but also in preparation for the Next 50 Years. With this event, we once again underlined the reputation of Ras Al Khaimah as the leading tourism destination welcoming visitors from across the world.”
#RAKNYE 2020 fireworks display was conducted in a six-act sequence starting with the countdown just before midnight. Ushering in the New Year with a spectacular tower of lights, 1,055.8 metres high, the next act was a ‘Happy New Year’ message written in the sky with firework drones. This was followed by a tribute to the UAE backed by orchestral music, celebrating the achievements of the nation and its people. It segued to the next act when hundreds of drones displayed the UAE’s 50th Anniversary logo. The finale was in two parts – a multi-colour display of lights and a super-massive expanse of white that illuminated the skyline.
Setting the first GUINNESS WORLD RECORDS™ title for the ‘Highest Altitude Multirotor/Drone Fireworks Display’ was the tower of fireworks 1,055.8 metres high, taller than any skyscraper in the world. The second GUINNESS WORLD RECORDS™ title was for the ‘Most Remote Operated Multirotors/Drones Launching Fireworks Simultaneously’, when 452 drones launched fireworks simultaneously to create the ‘Happy New Year’ visual in the sky.
The celebration was organised by following all social distancing protocols and other safety guidelines with the support of the National Authority for Emergency, Crisis & Disaster Management and the Ministry of Health & Prevention. Visitors watched the festivities from special Viewing Decks along Al Marjan Island and Al Hamra Village. Video link here
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211231005082/en/
Contact information
Nivine William
ASDA’A BCW | +97144507600
nivine.william@bcw-global.com
www.asdaa-bcw.com | www.arabyouthsurvey.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 18:16:00 EEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 17:28:00 EEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 16:00:00 EEST | Press release
Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading transformative and meaningful customer experiences. These leading organizations are turning everyday interactions into seamless, cross-channel journeys that deliver meaningful business impact and
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 16:00:00 EEST | Press release
Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On the demand side, with smart meter integration, Predict+ models each meter individually and performs extensive calculations on actual, historical, and average data to acc
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 15:30:00 EEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom